Skip to main content
. 2018 Mar 12;146(6):723–734. doi: 10.1017/S0950268818000444

Table 2.

Underlying medical conditions, complications and outcomes of varicella-related A&E attendance and inpatient admissions

A&E attendance in public hospitals Inpatient admission in public hospitals
N % N %
No. of cases 14 144 2860
Underlying medical conditions
Pregnancya 15 1.2 87 19.0
Immunodeficiency (any)b 0 110 3.8
Lymphoproliferative malignancy 0 50 1.7
Malignancy of solid organ/tissue 0 21 0.7
Transplant 0 22 0.8
HIV 0 5 0.2
Other immunodeficiency conditionc 0 25 0.9
Complicationb 97 0.7 575 20.1
Pneumonia 12 0.1 92 3.2
Varicella pneumonitis 4 0.0 10 0.3
Other pneumonia 8 0.1 82 2.9
Neurological disorder 6 0.0 35 1.2
Encephalitis 0 12 0.4
Ataxia 0 10 0.3
Meningitis 6 0.0 13 0.5
Myelitis 0 2 0.1
Other unspecified viral infection of the central nervous system 0 0
Septicaemia/sepsis 0 21 0.7
Bacterial infections (including scarlet fever and bacterial infection caused by Streptococcal and Staphylococcal species) 0 238 8.3
Bacterial superinfection of skin and/or soft tissue 14 0.1 101 3.5
Cellulitis, abscess and erysipelas 13 0.1 83 2.9
Impetigo 1 0.0 17 0.6
Fasciitis 0 3 0.1
Ophthalmic disorders (including conjunctivitis and keratoconjunctivitis) 11 0.1 14 0.5
Congenital varicella infection 0 0
Outcome
Hospitalisation 563 4.0 NA NA
Median length of stay (days) NA NA 4
Among cases with complications NA NA 5
Among cases without complications NA NA 4
ICU admission NA NA 19 0.7
Among cases with complications NA NA 6 1.0
Among cases without complications NA NA 13 0.6
Death 0 0.0 9 0.3
Among cases with complications 6 1.0
Among cases without complications 3 0.1
a

Pregnancy among females aged 20 years or above.

b

More than one type of immunodeficiency/complications were coded in some episode of A&E attendance and admission.

c

These include conditions such as white blood cell diseases, Thalassaemia major, aplastic anaemia, asplenia or other splenic diseases, other specified diseases with the participation of lymphoreticular and reticulohistiocytic tissue, patients undergoing chemotherapy or radiotherapy and other conditions affecting the immune system.